BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
See today's BioWorld Asia
Home
» In the clinic for Feb. 1-14, 2022
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
In the clinic for Feb. 1-14, 2022
Feb. 15, 2022
No Comments
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Akston, Antengene, Ascletis, Astellas, Astrazeneca, Biohaven, Chi-Med, Clarity, Eubiologics, Gilead Sciences, Glenmark, IGM, Kintor, Novavax, Opthea, Otsuka, Pardes, Pfizer, Pop, Prota, RDIF, Recce, Revive, Sanotize R&D, Scancell, Shionogi, Sumitovant, Sunovion, Telix, Windtree.
BioWorld Asia
Briefs
In the clinic